Salivary metabolites are promising non‐invasive biomarkers of hepatocellular carcinoma and chronic liver disease-Reference-Cited by-同舟云学术

Salivary metabolites are promising non‐invasive biomarkers of hepatocellular carcinoma and chronic liver disease

Published:2021-05-20 Issue:2 Volume:2 Page:33-44
ISSN:2642-3561
Container-title:Liver Cancer International
language:en
Short-container-title:Liver Cancer International

Author:

Hershberger Courtney E.¹,Rodarte Alejandro I.²,Siddiqi Shirin²,Moro Amika²,Acevedo‐Moreno Lou‐Anne²,Brown J. Mark³⁴,Allende Daniela S.⁵,Aucejo Federico²,Rotroff Daniel M.¹^ORCID

Affiliation:

1. Department of Quantitative Health Sciences Lerner Research InstituteCleveland Clinic Cleveland OH USA

2. Department of General Surgery Cleveland Clinic Cleveland OH USA

3. Department of Cardiovascular and Metabolic Sciences Lerner Research InstituteCleveland Clinic Cleveland OH USA

4. Center for Microbiome and Human Health Cleveland Clinic Cleveland OH USA

5. Department of Pathology Cleveland Clinic Cleveland OH USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lci2.25

Reference49 articles.

1. Cancer statistics, 2020

2. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030

3. Hepatocellular carcinoma

4. Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis

5. Incidence and Cofactors of Hepatitis C Virus-related Hepatocellular Carcinoma: A Prospective Study of 12,008 Men in Taiwan

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Gut Microbe-Derived Metabolites Are Associated with Hepatocellular Carcinoma;Biomedicines;2024-08-26

2. Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment;Gut;2024-08-22

3. The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC;Gut Microbes;2024-08-06

4. Salivary metabolites are promising noninvasive biomarkers of drug-induced liver injury;World Journal of Gastroenterology;2024-05-14

5. Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma;Cancers;2024-04-10